Among US patients who attempted to negotiate a medical bill, 93% had it reduced or eliminated, according to a 2024 LendingTree survey of 2,016 adults — and 66% received exactly what they requested. A peer-reviewed 2024 JAMA Health Forum study (n=1,135, nationally representative) found that patients who challenged bills achieved a price reduction 61.8% of the time, error correction 73.7% of the time, and some form of financial relief 75.8% of the time. Against this evidence, the same JAMA study found that 86.1% of patients who did not challenge their bill believed negotiation would not make a difference — a systematically false belief that the outcome data consistently refutes. LendingTree (2024) found that 41% of those who had medical debt never attempted to negotiate.
The gap between what non-negotiators believe (it won’t help) and what actually happens to those who try (61–93% success) is the clearest available signal of the opportunity cost of inaction. Medical bill negotiation is unfamiliar territory for most US patients, who tend to treat the stated price as fixed — a reasonable assumption in retail contexts that does not translate to healthcare, where list prices (chargemaster rates) are almost never what insurers pay, cash-pay discounts are standard, and billing departments have significant discretion to reduce, restructure, or forgive balances. Hospitals routinely offer self-pay or prompt-pay discounts off billed charges, and medical debt collectors — who typically buy delinquent accounts for a fraction of face value — have substantial room to settle for less than the stated amount. The stated amount on a medical bill is closer to a starting position than a fixed price.
The data here is almost entirely proxy-based. No survey has asked patients “do you regret not negotiating your medical bill?” — the 38% inaction-regret estimate is derived from the false-belief prevalence, not from a direct regret question. The action-side 5% estimate reflects the small minority who tried and got no reduction, noting that even they paid no more than non-negotiators. The JAMA and LendingTree success-rate figures differ because they sample different populations with different methods; the JAMA figure (62% for price reduction specifically) is more methodologically rigorous but based on a smaller, representative sample. Barriers to negotiation are real: 34% of non-negotiators cited discomfort with reaching out and 25.7% cited lack of time — these are genuine constraints, particularly for patients managing serious illness. Income-based charity care programs can further reduce bills independently of negotiation, which may lower the stakes for lower-income patients who qualify automatically.